CTOs on the Move

World Technologies

www.wtlxtal.com

 
World Technologies is a Shawnee, KS-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.wtlxtal.com
  • 14705 W 50th St
    Shawnee, KS USA 66216
  • Phone: 913.438.9825

Executives

Name Title Contact Details

Similar Companies

Plochman, Inc.

Plochman's is The Mustard Lover's Mustard. For 150 years, the Plochman family has been making Premium Mustards such as the classic Mild Yellow Squeeze Barrel, the Natural Stone Ground and Kosciusko brands, and a variety of specialty flavors.

HONBLUE

HONBLUE is a Honolulu, HI-based company in the Business Services sector.

Transport Specialties

Transport Specialties is a Long Beach, CA-based company in the Business Services sector.

Doster Mickes James Ullom Benson

Doster Mickes James Ullom Benson is a Chesterfield, MO-based company in the Business Services sector.

Oculis

Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.